Dr. Eric Nuermberger

powered by
COS Expertise®
Johns Hopkins University
School of Medicine
Medicine
Infectious Diseases
Assistant ProfessorAppointed: 2003
Johns Hopkins University
Bloomberg School of Public Health
International Health
Assistant ProfessorAppointed: 2004

Mailing Address

1550 Orleans Street
Room 107
Baltimore, Maryland 21231
United States

Contact Information

enuermb@jhmi.edu

Keywords

COS Keywords:

Drug Design, Infectious Diseases Or Agents, International Health, Tuberculosis.

Additional Terms:

Community-Acquired Pneumonia, Drug Development, Tuberculosis.

Memberships

American Society for Microbiology
American Thoracic Society
Infectious Diseases Society of America

Publications

  • Almeida D, Nuermberger E, Tyagi S, Bishai WR, Grosset J (Dec 2007) In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis., Antimicrobial agents and chemotherapy, 51 (12), 4261-6 Abstract
  • Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL (Dec 2007) Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model., PLoS medicine, 4 (12), e344 Abstract
  • Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, Johnson C, Aubry J, Nuermberger E, Grosset J (Nov 2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)., Antimicrobial agents and chemotherapy, 51 (11), 4029-35 Abstract
  • Byrne ST, Denkin SM, Gu P, Nuermberger E, Zhang Y (Aug 2007) Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model., Journal of medical microbiology, 56 (Pt 8), 1047-51 Abstract
  • Jain SK, Hernandez-Abanto SM, Cheng QJ, Singh P, Ly LH, Klinkenberg LG, Morrison NE, Converse PJ, Nuermberger E, Grosset J, McMurray DN, Karakousis PC, Lamichhane G, Bishai WR (Jun 2007) Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice., The Journal of infectious diseases, 195 (11), 1634-42 Abstract
  • Davies GR, Pym AS, Mitchison DA, Nuermberger EL, Grosset JH (Jan 2007) Evaluation of new antituberculosis drugs in mouse models., Antimicrobial agents and chemotherapy, 51 (1), 403; author reply 40 Abstract
  • Nuermberger E, Rosenthal I, Tyagi S, Williams KN, Almeida D, Peloquin CA, Bishai WR, Grosset JH (Aug 2006) Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis., Antimicrobial agents and chemotherapy, 50 (8), 2621-5 Abstract
  • Rosenthal IM, Williams K, Tyagi S, Peloquin CA, Vernon AA, Bishai WR, Grosset JH, Nuermberger EL (Jul 2006) Potent twice-weekly rifapentine-containing regimens in murine tuberculosis., American journal of respiratory and critical care medicine, 174 (1), 94-101 Abstract
  • Rosenthal IM, Williams K, Tyagi S, Vernon AA, Peloquin CA, Bishai WR, Grosset JH, Nuermberger EL (Dec 2005) Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis., American journal of respiratory and critical care medicine, 172 (11), 1457-62 Abstract
  • Nuermberger E, Tyagi S, Williams KN, Rosenthal I, Bishai WR, Grosset JH (Dec 2005) Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model., American journal of respiratory and critical care medicine, 172 (11), 1452-6 Abstract
  • Nuermberger E, Helke K, Bishai WR (Dec 2005) Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy., International journal of antimicrobial agents, 26 (6), 497-503 Abstract
  • Nuermberger E (Dec 2005) Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials., Pharmacotherapy, 25 (12 Pt 2), 134S-139S Abstract
  • Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G, Hardick J, Bartlett JG, Auwaerter PG, Rothman RE (Jul 2005) Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients., Journal of clinical microbiology, 43 (7), 3221-6 Abstract
  • Tyagi S, Nuermberger E, Yoshimatsu T, Williams K, Rosenthal I, Lounis N, Bishai W, Grosset J (Jun 2005) Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis, Antimicrobial Agents and Chemotherapy, 49 (6), 2289-93
  • Zetola N, Francis JS, Nuermberger EL, Bishai WR (May 2005) Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat, The Lancet Infectious Diseases, 5 (5), 275-86
  • Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG (Jan 2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 40 (1), 100-7
  • Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, O'Brien RJ, Vernon AA, Chaisson RE, Bishai WR, Grosset JH (Nov 2004) Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis, American Journal of Respiratory and Critical Care Medicine, 170 (10), 1131-4
  • Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, Grosset J, Bishai WR (Sep 2004) Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice, The Journal of Experimental Medicine, 200 (5), 647-57
  • Nuermberger E, Bishai WR, Grosset JH (Jun 2004) Latent tuberculosis infection., Seminars in respiratory and critical care medicine, 25 (3), 317-36 Abstract
  • Nuermberger EL, Bishai WR (May 2004) Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 38 Suppl 4, S363-71
  • Nuermberger E, Grosset J (Apr 2004) Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections, European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 23 (4), 243-55
  • Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH (Feb 2004) Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis, American Journal of Respiratory and Critical Care Medicine, 169 (3), 421-6
  • Nuermberger EL, Yoshimatsu T, Tyagi S, Bishai WR, Grosset JH (Feb 2004) Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG, Infection and Immunity, 72 (2), 1065-71
  • Nuermberger E, Bishai WR (Jan 2004) The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 38 (1), 99-103
  • Nuermberger EL, Bishai WR (Sep 2003) Significance of macrolide resistance in Streptococcus pneumoniae, The Journal of Antimicrobial Chemotherapy, 52 (3), 524-5; author reply
  • Lanzkron S, Moliterno AR, Norris EJ, Gould SA, Segal J, Nuermberger EL, Ness PM (Nov 2002) Polymerized human Hb use in acute chest syndrome: a case report, Transfusion, 42 (11), 1422-7
  • Yoshimatsu T, Nuermberger E, Tyagi S, Chaisson R, Bishai W, Grosset J (Jun 2002) Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis, Antimicrobial Agents and Chemotherapy, 46 (6), 1875-9
  • Myers JS, Nuermberger E (Apr 2002) Cases from the Osler Medical Service at Johns Hopkins University. Diagnosis: Polymorphic population of mature and immature hematopoietic cells consistent with extramedullary hematopoiesis, The American Journal of Medicine, 112 (6), 494-5
  • Nuermberger E (Jan 2002) Cases from the Osler medical service at Johns Hopkins university, The American Journal of Medicine, 112 (1), 70-1
  • Eustace JA, Nuermberger E, Choi M, Scheel PJ Jr, Moore R, Briggs WA (Sep 2000) Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids, Kidney International, 58 (3), 1253-60

Profile Details

Last Updated: 1/29/2008

COS Expertise ID #1228217
Reference this profile directly: http://myprofile.cos.com/elnuerm